Life Science REIT PLC (LABS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Life Science REIT PLC (LABS) has a cash flow conversion efficiency ratio of 0.004x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX958.00K ≈ $116.56 USD) by net assets (GBX233.06 Million ≈ $28.36K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See LABS net asset quality index to measure how much of total assets are equity-financed.
Life Science REIT PLC - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Life Science REIT PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Life Science REIT PLC (LABS) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Life Science REIT PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Life Science REIT PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rakovina Therapeutics Inc
V:RKV
|
-0.548x |
|
Midwich Group PLC
LSE:MIDW
|
0.268x |
|
Fintech Chain Ltd
AU:FTC
|
-0.019x |
|
Mobeus Income And Growth Vct Plc
LSE:MIX
|
-0.004x |
|
Drugs Made In America Acquisition Corp. Rights
NASDAQ:DMAAR
|
N/A |
|
Middlefield Canadian Income PCC - Middlefield Canadian Income - GBP PC
LSE:MCT
|
0.005x |
|
CENTURION FIN.A-C ZY -10
F:6F4
|
N/A |
|
Monarca Minerals Inc
V:MMN
|
0.008x |
Annual Cash Flow Conversion Efficiency for Life Science REIT PLC (2021–2024)
The table below shows the annual cash flow conversion efficiency of Life Science REIT PLC from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Life Science REIT PLC.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX262.77 Million ≈ $31.97K |
GBX12.92 Million ≈ $1.57K |
0.049x | +83.22% |
| 2023-12-31 | GBX283.75 Million ≈ $34.52K |
GBX7.62 Million ≈ $926.53 |
0.027x | +887.98% |
| 2022-12-31 | GBX319.45 Million ≈ $38.87K |
GBX-1.09 Million ≈ $-132.38 |
-0.003x | -133.75% |
| 2021-12-31 | GBX350.58 Million ≈ $42.66K |
GBX3.54 Million ≈ $430.47 |
0.010x | -- |
About Life Science REIT PLC
Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.